Evidence map›Paper›PMID 41239137›Full record

ArticleCellular and molecular neurobiology2025

Systematic Analysis of SH-SY5Y Differentiation Protocols and Neuronal Subtype Abundance.

Marina Prisacar, Svenja Esser, Maximilian Hausherr, Bilhan Karacora, Yulia Vyushkova, Martin Eisenacher, Robin Grugel, Katrin Marcus, Britta Eggers

Abstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marina PrisacarMedizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801, Bochum, Germany.
Svenja EsserMedizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801, Bochum, Germany.
Maximilian HausherrMedizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801, Bochum, Germany.
Bilhan KaracoraMedizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801, Bochum, Germany.
Yulia VyushkovaMedizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801, Bochum, Germany.
Martin EisenacherMedizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801, Bochum, Germany.
Robin GrugelMedizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801, Bochum, Germany.
Katrin MarcusMedizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801, Bochum, Germany.
Britta EggersMedizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, 44801, Bochum, Germany. britta.eggers@rub.de.

Funding

Bundesministerium für Bildung und Forschung 13N16290Bundesministerium für Bildung und Forschung W-de.NBI-005Ministerium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen 233-1.08.03.03-031‑68079Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen 111.08.03.05-133974
6 · The paper itself

Abstract

The SH-SY5Y cell line is a triple-cloned subline of SK-N-SH cells originally isolated in the early 1970s from a bone marrow biopsy of a four-year-old female patient suffering from neuroblastoma. Since then, this cell line has been used as one of the major cell culture models in neuroscience and to study neurodegeneration, as it comprises many of the biochemical and functional properties of neural precursor cells. Differentiation of neuronal precursor cells into a more mature phenotype represents one of the key steps and directed differentiation utilising various reagents is thought to provoke a defined neuronal subtype. Unfortunately, until now there is no consensus, which protocol shall be utilised to reach a specific neuronal subtype. Thus, the aim of the present work was to evaluate four common standard protocols for the differentiation of SH-SY5Y cells and to investigate the respective influences of varying parameters of these differentiation strategies. For this purpose, morphological analyses, mass spectrometry-based quantification of specific marker proteins, time-course protein expression profiling and global proteomics were conducted. On the level of morphology a low serum concentration favoured the abundance of mature neuronal cells containing long and branched neurites. Further low serum levels favoured the expression of dopaminergic marker proteins, in particular DDC, especially when utilising retinoic acid as differentiation agent. Our study clearly shows that an a priori characterisation of SH-SY5Y cells is indispensable to assess the abundance of neuronal subtypes and by that to ensure that the utilised differentiation approach is appropriately aligned with the specific research question.

Indexed as

Cell DifferentiationNeuronsCell Line, TumorFemaleHumansProteomicsTretinoinTretinoinDifferentiationMass spectrometryNeuronal subtypeProteomicsSH-SY5Y

Identifiers

PMID41239137
PMCPMC12618781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.